Cargando…
Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine
BACKGROUND: In non-human primates (NHPs) and humans, partial protection from HIV/SIV infection or suppression of replication is achievable by Env-binding antibodies and Gag-specific CD8+ T-cells targeting protective epitopes. Unfortunately, such T-cell responses are frequently dominated by responses...
Autores principales: | Schwerdtfeger, Melanie, Andersson, Anne-Marie Carola, Neukirch, Lasse, Holst, Peter Johannes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534914/ https://www.ncbi.nlm.nih.gov/pubmed/31126293 http://dx.doi.org/10.1186/s12967-019-1924-1 |
Ejemplares similares
-
Mucosal Vaccination with Heterologous Viral Vectored Vaccine Targeting Subdominant SIV Accessory Antigens Strongly Inhibits Early Viral Replication
por: Xu, Huanbin, et al.
Publicado: (2017) -
Virus-Like-Vaccines against HIV
por: Andersson, Anne-Marie C., et al.
Publicado: (2018) -
Subdominant Antigens in Bacterial Vaccines: AM779 Is Subdominant in the Anaplasma marginale Outer Membrane Vaccine but Does Not Associate with Protective Immunity
por: Albarrak, Saleh M., et al.
Publicado: (2012) -
Adenovirus based virus-like-vaccines targeting endogenous retroviruses can eliminate growing colorectal cancers in mice
por: Neukirch, Lasse, et al.
Publicado: (2019) -
Gag and env conserved element CE DNA vaccines elicit broad cytotoxic T cell responses targeting subdominant epitopes of HIV and SIV Able to recognize virus-infected cells in macaques
por: Hu, Xintao, et al.
Publicado: (2018)